| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.16 | 0.4 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.12 | 0.4 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.4 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.27 | 0.4 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.4 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |